ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 86 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2022. The put-call ratio across all filers is 5.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $15,227 | -0.9% | 21,753 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $15,358 | -53.5% | 21,753 | 0.0% | 0.00% | -60.0% |
| Q3 2022 | $33,000 | +50.0% | 21,753 | 0.0% | 0.01% | +66.7% |
| Q2 2022 | $22,000 | -29.0% | 21,753 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $31,000 | -72.8% | 21,753 | 0.0% | 0.00% | -75.0% |
| Q4 2021 | $114,000 | -10.2% | 21,753 | 0.0% | 0.02% | -20.0% |
| Q3 2021 | $127,000 | -27.4% | 21,753 | 0.0% | 0.02% | -28.6% |
| Q2 2021 | $175,000 | -3.3% | 21,753 | 0.0% | 0.03% | -6.7% |
| Q1 2021 | $181,000 | +9.0% | 21,753 | -0.9% | 0.03% | -23.1% |
| Q4 2020 | $166,000 | -29.1% | 21,948 | 0.0% | 0.04% | -45.8% |
| Q3 2020 | $234,000 | -29.7% | 21,948 | 0.0% | 0.07% | -29.4% |
| Q2 2020 | $333,000 | +82.0% | 21,948 | 0.0% | 0.10% | +43.7% |
| Q1 2020 | $183,000 | -51.7% | 21,948 | -2.2% | 0.07% | -50.0% |
| Q4 2019 | $379,000 | – | 22,448 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,183,795 | $50,118,000 | 32.35% |
| ORACLE INVESTMENT MANAGEMENT INC | 4,187,145 | $96,095,000 | 21.04% |
| Selkirk Management LLC | 341,450 | $7,836,000 | 3.99% |
| NEXT CENTURY GROWTH INVESTORS LLC | 607,067 | $13,932,000 | 1.62% |
| Chicago Capital, LLC | 630,053 | $14,460,000 | 1.00% |
| Cannell & Co. | 1,115,239 | $25,595,000 | 0.91% |
| GRIFFIN ASSET MANAGEMENT, INC. | 252,893 | $5,804,000 | 0.85% |
| Trellus Management Company, LLC | 24,648 | $566,000 | 0.82% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $3,557,000 | 0.79% |
| ORACLE INVESTMENT MANAGEMENT INC | 967,900 | $2,993,000 | 0.66% |